What this study is
Background:
Genetic testing called "sequencing" helps researchers look at DNA. Genes are made of DNA and are the instructions for our bodies to function. We all have thousands of genes. DNA variants are differences in genes between two people. We all have lots of variants. Most are harmless and some cause differences like blue or brown eyes. A few variants can cause health problems.
Objective:
To understand the genetics of immune disorders various health conditions, as well as outcomes of clinical genomics and genetic counseling services performed under this protocol.
Eligibility:
Participants in other NIH human subjects research protocols - either at the NIH Clinical Center (CC) or at Children's National Health System (CNHS) - (aged 0-99 years), and, in select cases, their biological relatives
Design:
Researchers will study participant's DNA extracted from blood, saliva, or another tissue sample, including previously collected samples we may have stored at the NIH. Researchers will look at participant's DNA in great detail. We are looking for differences in the DNA sequence or structure between participants and other people.
Participants will receive results that:
- Are important to their health
- Have been confirmed in a clinical lab
- Suggest that they could be at risk for serious disease that may affect your current or future medical management.
Some genetic information we return to participants may be of uncertain importance.
If genetic test results are unrelated to the participant's NIH evaluations, then we will not typically report:
- Normal variants
- Information about progressive, fatal conditions that have no effective treatment
- Carrier status (conditions you don t have but could pass on)
The samples and data will be saved for future research.
Personal data will be kept as private as possible.
If future studies need new information, participants may be contacted.
Study details
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Conditions
- Atopy · Primary Immunodeficiency · Autoimmunity · Autoinflammation
- Enrolling
- 20,000 people
- Starts
- 2017-07-31
- Est. completion
- 2042-07-01
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 1 Day – 100 YearsSex ALLHealthy volunteers AcceptedYou may qualify if
- Proband participants: must be individuals under investigation by another NIH protocol on which they are co-enrolled, or are referred from the GDMCC protocol "Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults" (NCT04702243) or "Use of Tiered Genetic Sequencing and Specialty Referral for Identifying and Managing Rare Genetic Causes of Chronic Suppurative Respiratory Disease" (External study #: 26-1761). Probands may have a disease under investigation or be healthy volunteers.; Biological relatives: biologically related to a proband participant.
- Aged 0-99 years.
- Participants must be willing to undergo genetic testing.
- Participants must be willing to allow samples to be stored for future research.
- Participants must be willing to have their de-identified genomic data shared, for example in a controlled access databases like the Database of Genotypes and Phenotypes (dbGaP).
- To complete surveys and interviews:; Proficient with the English language.; Able to provide informed consent.
- Adult healthy volunteers must be able to provide informed consent.
You can't join if
- Any condition that, in the opinion of the investigator, contraindicates participation in this study is a reason for exclusion.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (2)
2 openChildren's National Health System
Washington D.C., District of Columbia, United States
- Michael Keller, MD · Contact202-476-5843mkeller@childrensnational.org
RecruitingNational Institutes of Health Clinical Center
Bethesda, Maryland, United States
- For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) · Contact800-411-1222 ext. TTY dial 711ccopr@nih.gov
Recruiting
Study team
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Study ID 170122
Principal investigator
Morgan N Similuk
National Institute of Allergy and Infectious Diseases (NIAID)
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.